As part of CRA’s issues leadership initiative to challenge industry thinking on rare diseases, we assembled a panel of CRA experts to discuss the opportunities and challenges posed by the latest therapeutic breakthroughs in conditions that affect fewer than one in 2,000 people. Neil Turner moderates a discussion with Greg Bell, Kevin Brubacher, Ned Kitfield, Cécile Matthews, and Tim Wilsdon.
Dr. Annabelle Fowler featured in ERE spotlight series
The feature highlights Dr. Fowler’s path to becoming an expert witness, her approach to solving complex problems, and what she enjoys most about her work....